LoginRegister

    Hester Biosciences Q4 net up 27 percent

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  
    Hester Biosciences Q4 net up 27 percent

    New Delhi: Hester Biosciences reported 26.72 percent rise in standalone net profit to Rs 9.01 crore for the March quarter, 2017-18.


    It had posted the net profit of Rs 7.11 crore for the January-March period of 2016-17, Hester Biosciences said in a filing to BSE.


    The standalone net sales of the company rose to Rs 37.48 crore for the fourth quarter of last fiscal as against Rs 35.59 crore in the year-ago period.


    For the entire 2017-18, the standalone net profit of Hester rose to Rs 30.55 crore. It was Rs 24.94 crore in the preceding fiscal.


    Its net sales rose to Rs 135.25 crore for the fiscal ended March 2018. It was Rs 125.57 crore in 2016-17.


    Total dividend for 2017-18 will be Rs 10 per equity share as against Rs 5.30 per equity share in 2016-17, the company said.

    dividendFinancial resultsHester BiosciencesMarch-quarternet profitQ4
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      sidekick